We report findings of a case study of Civica Rx, a U.S. nonprofit pharmaceutical company whose model is based on long-term hospital membership agreements with minimum volume commitments and buffer stock requirements.
*This content is in the process of Section 508 review. If you need immediate assistance accessing this content, please submit a request to Oluwarantimi Adetunji, 202-923-5996, oluwarantimi.adetunji@hhs.gov. Content will be updated pending the outcome of the Section 508 review.
Related Products: